L&C BIO Co.,LTD (KOSDAQ: 290650)
South Korea
· Delayed Price · Currency is KRW 16,720
0.00 (0.00%)
Sep 11, 2024, 2:56 PM KST
L&C BIO Co.,LTD Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Market Capitalization | 377,930 | 657,862 | 524,021 | 830,267 | 754,757 | 188,399 | Upgrade
|
| Market Cap Growth | -28.80% | 25.54% | -36.89% | 10.00% | 300.62% | 32.53% | Upgrade
|
| Enterprise Value | 429,956 | 657,447 | 594,079 | 823,218 | 740,027 | 163,736 | Upgrade
|
| Last Close Price | 16660.00 | 29000.00 | 23020.75 | 36396.67 | 34260.02 | 8461.16 | Upgrade
|
| PE Ratio | 7.86 | 13.83 | 115.10 | 58.75 | 69.38 | 25.64 | Upgrade
|
| PS Ratio | 5.25 | 9.55 | 9.97 | 18.18 | 22.89 | 6.46 | Upgrade
|
| PB Ratio | 2.55 | 4.19 | 4.86 | 8.90 | 12.32 | 3.13 | Upgrade
|
| P/FCF Ratio | -14.29 | -17.96 | -12.02 | 1266.25 | 171.43 | 42.11 | Upgrade
|
| P/OCF Ratio | -37.20 | -54.22 | -86.25 | 76.12 | 101.73 | 29.30 | Upgrade
|
| EV/Sales Ratio | 5.97 | 9.55 | 11.30 | 18.02 | 22.44 | 5.62 | Upgrade
|
| EV/EBITDA Ratio | 33.22 | 49.05 | 42.46 | 51.22 | 83.04 | 16.18 | Upgrade
|
| EV/EBIT Ratio | 61.39 | 84.85 | 62.64 | 62.51 | 101.04 | 18.13 | Upgrade
|
| EV/FCF Ratio | -11.01 | -17.95 | -13.62 | 1255.50 | 168.08 | 36.60 | Upgrade
|
| Debt / Equity Ratio | 0.51 | 0.52 | 0.76 | 0.07 | 0.25 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | 6.33 | 6.13 | 5.86 | 0.43 | 1.69 | 0.18 | Upgrade
|
| Debt / FCF Ratio | -2.10 | -2.24 | -1.88 | 10.42 | 3.41 | 0.40 | Upgrade
|
| Asset Turnover | 0.31 | 0.30 | 0.34 | 0.49 | 0.45 | 0.47 | Upgrade
|
| Inventory Turnover | 0.78 | 0.85 | 1.10 | 1.69 | 1.87 | 1.78 | Upgrade
|
| Quick Ratio | 0.64 | 0.77 | 1.37 | 5.77 | 9.97 | 11.29 | Upgrade
|
| Current Ratio | 1.23 | 1.28 | 3.43 | 8.45 | 12.38 | 13.55 | Upgrade
|
| Return on Equity (ROE) | 36.88% | 36.67% | 5.66% | 20.17% | 19.99% | 14.95% | Upgrade
|
| Return on Assets (ROA) | 1.87% | 2.10% | 3.86% | 8.76% | 6.24% | 9.13% | Upgrade
|
| Return on Capital (ROIC) | 2.00% | 2.26% | 4.09% | 9.33% | 6.62% | 9.74% | Upgrade
|
| Earnings Yield | 12.73% | 7.35% | 0.87% | 1.66% | 1.43% | 3.85% | Upgrade
|
| FCF Yield | -10.33% | -5.57% | -8.32% | 0.08% | 0.58% | 2.37% | Upgrade
|
| Dividend Yield | 0.60% | 0.34% | - | - | - | - | Upgrade
|
| Payout Ratio | 4.63% | 2.31% | 24.54% | 7.80% | 6.74% | - | Upgrade
|
| Buyback Yield / Dilution | -9.32% | -8.98% | -1.74% | -1.83% | 0.33% | -14.34% | Upgrade
|
| Total Shareholder Return | -8.72% | -8.64% | -1.74% | -1.83% | 0.33% | -14.34% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.